European Journal of Clinical Microbiology & Infectious Diseases

Papers
(The H4-Index of European Journal of Clinical Microbiology & Infectious Diseases is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection492
Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome202
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review113
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship94
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review88
Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France83
Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile82
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions58
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa57
Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review54
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit49
Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae48
Antimicrobial resistance in Clostridioides difficile47
Effectiveness of favipiravir in COVID-19: a live systematic review45
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting43
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study39
Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-1938
Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples37
Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing37
Expression and co-expression analyses of TMPRSS2, a key element in COVID-1937
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection37
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature36
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays35
The role of potentiating mutations in the evolution of pandemic Escherichia coli clones35
Sensitive detection and quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR34
Changes of intestinal microflora of breast cancer in premenopausal women34
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects32
Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015–201932
Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey32
Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients31
Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China31
Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study31
0.10287308692932